Aquestive Therapeutics vs Rockwell Medical
Rockwell Medical is the larger business, with $69.3m of revenue in fiscal 2025 against $44.5m for Aquestive Therapeutics (1.6 times as much). Aquestive Therapeutics grew faster (-22.6% against -31.8%). Rockwell Medical kept more of each dollar of sales as profit: a net margin of -7.7% against -188.1%.
| Latest fiscal year | Aquestive TherapeuticsAQST, 2025 | Rockwell MedicalRMTI, 2025 |
|---|---|---|
| Revenue | $44.5m | $69.3m |
| Revenue growth | -22.6% | -31.8% |
| Net income | −$83.8m | −$5.3m |
| Operating margin | -159.5% | — |
| Net margin | -188.1% | -7.7% |
| Return on equity | — | -15.3% |
| Free cash flow | −$53.0m | −$1.2m |
| Cash | $121m | $10.7m |
| Total debt | $55.0m | $8.8m |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 147 | 157 |
| Market value | $485m | $32.2m |
| Price vs our value range | — | Above our value range |
| Moat score | 24 (Weak) | 35 (Weak) |
| Insider trades, 12 months | 0 buys, 16 sales | 0 buys, 4 sales |